Elias Zerhouni

ModeX Therapeutics, Co-Founder
OPKO Health, President and Vice Chairman of the Board of Directors

Dr. Elias Zerhouni co-founded ModeX Therapeutics and is Chairman of the Board. Dr. Zerhouni started his academic career in biomedical imaging and engineering; he served as Chair of his department, and then Executive Vice-Dean and Dean of Research of the Johns Hopkins University School of Medicine. He was the 15th Director of the NIH from 2002 to 2008, and subsequently served as one of the first Presidential Science Envoys to foster scientific and technological collaborations with other nations. Dr. Zerhouni was President for Global Research and Development at Sanofi from 2011 to 2018. During his tenure, he led the transformation of the R&D organization, resulting in marked improvement of R&D productivity, and presided over 30 programs – 11 of which received regulatory approvals and launched commercially. He is an experienced entrepreneur, having founded or co-founded several start-up companies which have successfully reached market stage and profitability.

Dr. Zerhouni is a member of the National Academy of Medicine and the National Academy of Engineering. He served on the National Cancer Institute’s Board of Scientific Advisors before becoming NIH Director. He was the founding Chief Scientific Editor of Science Translational Medicine of the American Association for the Advancement of Sciences (AAAS). He served as a Senior Fellow for the Bill and Melinda Gates Foundation for Global Health. He is a member of the board of the Danaher Corporation, B-Flexion capital, the Lasker Foundation, Research America and the Foundation for NIH.

He is now President of OPKO Health, and Vice Chair of the Board of Directors.